Press ReleasesFebruary 11, 2023β€’3 min read

Japan 5G Devices Market size of US$23.006 billion by 2028

Key Highlights

Knowledge Sourcing Intelligence releases the publication of a new analysis report on the market β€œ...

Knowledge Sourcing Intelligence releases the publication of a new analysis report on the market β€œJapan 5G Devices Market - which is projected from 2022 to 2028”.

Japan 5G devices market is estimated to grow at a CAGR of 10.49% to reach a market size of US$23.006 billion by 2028.

Japan 5G devices market are anticipated to surge during the projected period primarily due to the increasing adoption of 5G networks in addition to the implementation of those into consumer devices such as smartphones and others. For instance, SoftBank launched its 5G millimeter wave (mmWave) service in Japan in March 2021, using Qualcomm Snapdragon 5G Mobile Platforms and Modem-RF Systems. SoftBank first marketed the "Pocket WiFi 5G A004ZT" 5G mmWave mobile hotspot. Qualcomm claims that Qualcomm Technologies' 5G mmWave products power all the initial 5G mmWave-compatible mobile devices in SoftBank's lineup, including 5G smartphones.

As per the report, the market is expected to grow at a steady pace. 

With the rising use of 5G connectivity in Japan, various operators have announced plans to increase their 5G coverage, which will influence the Japanese 5G device market. DoCoMo, for example, had approximately 82 million customers in March 2021, making it the largest of Japan's main mobile providers. The provider, which debuted its 5G service in 2020, plans to have 70% of the country covered by 5G by the first part of 2023. Therefore, due to such developments made in the 5G ecosystem by the operators in Japan, the market for 5G devices in this region is projected to grow during the upcoming years.

Based on device type, the market are segregated into smartphones, modules, FWA CPE, industrial routers, and others. The smartphones and FWA CPE segment are anticipated to account for the highest number of shares in the market due to the rising implementation of the 5G network into these products. For instance, in May 2020, according to Fibocom, the FG360-JP solution passed interoperability testing (IOT) with NTT DOCOMO and has received the JATE and TELEC certifications required for wireless goods to be utilized in Japan. The module on NTT DOCOMO's 5G network can allow a broad range of IoT applications, including FWA CPE, ODU, gateway, router, MIFI, industrial monitoring, telemedicine, and so on.

Based on the 5G deployment, the market are classified into Standalone (SA) and Non-Standalone (NSA). With the rising deployment of the 5G Standalone (SA) network in the region, this segment is expected to expand. For instance, KDDI, a Japanese telecom company, launched the first ever commercially available 5G standalone open radio access network (Open RAN) in February 2022. The construction of O-RAN compatible 5G Open vRAN sites by KDDI utilizing Samsung's virtualized technology is a significant step toward attaining the connectivity and speed necessary for the next wave of wireless networks. Furthermore, SoftBank introduced 5G Standalone services in October 2021 in connection with the release of its new 5G-compatible SoftBank Air terminal, dubbed "Air Terminal 5".

As a part of the report, the major players operating in the Japan 5G devices market, that have been covered include Samsung Electronics Co., Ltd, Apple Inc., Fibocom, MediaTek Inc., Fujikura Ltd, Telit Communications PLC, Siemens, and, Lenovo.

View a sample of the report or purchase the complete study at https://www.knowledge-sourcing.com/report/japan-5g-devices-market

This analytics report segments the Japan 5G devices market on the following basis:

  • By Device Type
    • Smartphones
    • Industrial Routers
    • FWA CPE
    • Modules
    • Others
  • By 5G Deployment
    • Standalone (SA)
    • Non-Standalone (NSA)
  • By Device Capability
    • Baseline Devices
    • Redcap Devices

Have questions?

More Press Releases

Aug 5, 2026

Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031

The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.

Click here to read→
Jul 30, 2026

Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%

The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.

Click here to read→
Jul 24, 2026

Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031

The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.

Click here to read→